A written policy increases compliance with guidelines for therapeutic anticoagulation prior to elective direct current cardioversion of atrial fibrillation

Journal of Cardiovascular Nursing

Volumn 22, Issue 5, 2007, Pages 417-421

  Fus, Allison M ^a   Kim, Michael H ^b   Haw, Janet M ^a   Trohman, Richard G ^a,c,d   Stephan, Elaine ^a,c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c Rush University Medical Center ^*

^d Biosense Webster Belgium   (Belgium)

Author keywords

Anticoagulation; Atrial fibrillation; Direct current cardioversion; Stroke

Indexed keywords

ANTICOAGULANT AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVERSION; ECHOGRAPHY; EVALUATION; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; METHODOLOGY; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINE; STANDARD; TEACHING; THROMBOEMBOLISM; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ATRIAL FIBRILLATION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ELECTRIC COUNTERSHOCK; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; PRACTICE GUIDELINES; TEACHING MATERIALS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 34548329653     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/01.JCN.0000287039.30810.2e     Document Type: Article

References (27)

1. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med. 1995;155:469-473.
2. Offutt C. Atrial fibrillation in the heart failure population. J Cardiovasc Nurs. 2004;19:S3-S10.
3. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol. 1992;19:851-855.
4. Fuster V, Ryden LE, Asinger RW, et al. ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation). J Am Coll Cardiol. 2001;38:1231-1265.
5. Opolski G, Stanislawska J, Goreck A, et al. Amiodarone in restoration and maintenance of sinus rhythm in patients with chronic atrial fibrillation after unsuccessful direct-current cardioversion. Clin Cardiol. 1997;20:337-340.
6. Klein AL, Grimm RA, Murray RD, et al. Use of transesophageal echocardiography to guide cardioversion in patients with atrial fibrillation. N Engl J Med. 2001;344:1411-1420.
7. Anderson M, Kirk M. Anticoagulation in atrial fibrillation. Med Health. 2004;87:98-100.
8. Sherman DG, Kim SG, Boop BS, et al. Occurrence and characteristics of stroke events in the atrial fibrillation follow-up investigation of sinus rhythm management (AFFIRM) study. Arch Intern Med. 2005;165:1185-1191.
9. Ederhy S, Cohen A. Optimizing stroke prevention in nonvalvular atrial fibrillation. Expert Opin Pharmacother. 2006;7:2079-2094.
10. Ederhy S, Meuleman C, Hammoudi N, Janower S, Boccara F, Cohen A. Preventing cerebrovascular accidents during atrial fibrillation. Presse Med. 2005;34:1315-1324.
11. Mitchell ARJ. Will this be the end of the anticoagulation clinic for patients with atrial fibrillation? Curr Drug Targets Cardiovasc Haematol Disord. 2005;5:405-408.
12. Diener HC. Stroke prevention using the oral direct thrombin inhibitor ximelagatran in patients with non-valvular atrial fibrillation. Cerebrovasc Dis. 2006;21:279-293.
13. Maeda K, Sakai T, Hira K, et al. Physicians' attitudes toward anticoagulation therapy in patients with chronic atrial fibrillation. Intern Med. 2004;43:553-560.
14. Mead GE, Elder AT, Faulkner S, Flapan AD. Cardioversion for atrial fibrillation: the views of consultant physicians, geriatricians and cardiologists. Age Ageing. 1999;28:73-75.
15. Callegari S, Pini M, Andreoli L. Guidelines and clinical practice: anticoagulant therapy and cardioversion in atrial fibrillation. G Ital Cardiol. 1999;29:1157-1163.
16. Muller-Oerlinghausen B, Rostock T. Pharmacologic management of atrial fibrillation by specialists in internal medicine, cardiologists, and general practitioners (GPs) in Berlin. Med Klin. 2003;98:359-363.
17. Singer DE, Albers GW, Dalen JE, Go AS, Halperin JL, Manning WJ. Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on antithrombotic and thrombolytic therapy. Chest. 2001;126:429S-456S.
18. Mehri SM, Havill JH, Montgomery C. A written guideline implementation can lead to reductions in laboratory testing in an intensive care unit. Anaesth Intensive Care. 1997;25:33-37.
19. Warren DK, Yokoe DS, Climo MW, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol. 2006;27:8-13.
20. Lewis CE, Montgomery K. The HIV-testing policies of US hospitals. JAMA. 1990;264:2764-2767.
21. Sovik O, Naess AC. Incidence and content of written guidelines for "do not resuscitate" orders. Survey of six different somatic hospitals in Oslo. Tidsskr Nor Laegeforen. 1997;117:4206-4209.
22. Nichol KL, Grimm MB, Peterson DC. Immunizations in long-term care facilities: policies and practice. J Am Geriatr Soc. 1996;44:349-355.
23. Manias E, Street A. Legitimation of nurses' knowledge through policies and protocols in clinical practice. J Adv Nurs. 2000;32:1467-1475.
24. Fontaine A, Mahe I, Bergmann JF, et al. Effectiveness of written guidelines on the appropriateness of thromboprophylaxis prescriptions for medical patients: a prospective randomized study. J Intern Med. 2006;260:369-376.
25. Kim MH, Krishnan K, Jain S, Decena B. Time course and frequency of subtherapeutic anticoagulation for newly prescribed warfarin sodium anticoagulation before elective cardioversion of atrial fibrillation or flutter. Am J Cardiol. 2001;88:1428-1431.
26. Corrado G, Beretta S, Sormani L, et al. Prevalence of atrial thrombi in patients with atrial fibrillation/flutter and subtherapeutic anticoagulation prior to cardioversion. Eur J Echocardiogr. 2004;5:25.
27. Gallagher MM, Hennessy BJ, Edvardsson N, et al. Embolic complications of direct current cardioversion of atrial arrhythmias: association with low intensity of anticoagulation at the time of cardioversion. J Am Coll Cardiol. 2002;40:926-933.